NCT00848562View on ClinicalTrials.gov

Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

NACompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Acute Myocardial InfarctionCongestive Heart Failure

Interventions

DRUG

Nicorandil

Oral administration of nicorandil (15 mg/day)

Trial Locations (1)

612-8026

Toujinkai Hospital, Kyoto

All Listed Sponsors

lead

Toujinkai Hospital

OTHER

NCT00848562 - Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients | Biotech Hunter | Biotech Hunter